Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/25/2025

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Pain and Inflammation Management

Introduction to Nabumetone

  • Nabumetone has demonstrated a more favorable GI safety profile compared to many traditional NSAIDs, with a lower incidence of peptic ulcers, perforations, and bleeding, according to the American Gastroenterological Association 1

Cardiovascular Risks

  • All NSAIDs, including nabumetone, may increase the risk of cardiovascular events, and should be used with caution in patients with cardiovascular disease, as recommended by the American Heart Association 2
  • Data from Kaiser Permanente showed an increased risk of thromboembolic events with nabumetone, similar to other NSAIDs like indomethacin and naproxen, highlighting the need for careful patient selection and monitoring 1

Prescribing Considerations

  • When prescribing nabumetone, evaluate gastrointestinal, renal, and cardiovascular status before initiating therapy, and monitor for signs of GI bleeding, especially in high-risk patients, as suggested by the European League Against Rheumatism 3
  • Use the lowest effective dose for the shortest duration possible to minimize risks, as recommended by the American College of Cardiology 2
  • Consider gastroprotective agents, such as proton pump inhibitors (PPIs), in high-risk patients to reduce the risk of GI complications, according to the American Gastroenterological Association 4

Dosage and Administration

  • Standard dosing for nabumetone is 1-2g once daily, typically at bedtime, with dosage adjustment may be needed in elderly patients, those with active rheumatic disease, or hepatic impairment 1